共查询到20条相似文献,搜索用时 156 毫秒
1.
2.
3.
4.
5.
电子病历在医院药学中的作用 总被引:1,自引:0,他引:1
目的利用电子病历提供的信息,促进医院药学发展。方法从临床查房、在线实时用药监护、电子药历、药物不良反应监测、药物经济学评价等方面论述电子病历在医院药学中的作用。结果电子病例在医院药学中的作用:①建立新的临床查房工作模式,做好查房前期准备工作,增加查房目的性和自信心;②启用已建立的药学电子辞典,对医嘱进行后台在线实时监护,促进合理用药;③建立同步电子药历;④提高药物不良反应报表的数量和质量,避免药源性疾病的发生,促进药物不良反应监测工作的进展;⑤促进药物经济学评价。结论电子病历具有纸张病历无法比拟的优势,充分发挥电子病历的动态信息源作用,将会促进医院药学的快速发展。 相似文献
6.
手机处方集药品供应动态查询系统的研发 总被引:1,自引:0,他引:1
目的:确保医、药、护工作人员随时随地掌握医院药品信息,提高医疗质量和药学服务水平。方法:结合医院药品处方集,充分利用医院局域网平台,采用嵌入式应用软件技术研发手机处方集药品供应动态查询系统。结果:该系统涉及药品涵盖院内所有品种,数据获取可定时更新,药物信息查询便捷,系统安全性考虑全面。结论:该系统开拓了高效快捷查询药品信息、掌握药品供应动态变化的新方式。 相似文献
7.
目的:充分利用医院的网络资源为临床医务工作者提供网络药学信息服务,促进合理用药。方法:在医院网络服务器上以Access2000建立数据库,采用动态网页技术建设药学网站并加以应用。结果:由于充分利用了网络在信息传输、信息共享方面的优势,试运行一段时间后,药学网站取得了较好的效果,使我院药学信息工作提高到了一个新的水平。结论:网络药学是现代医院药学的重要内容之一,应重视其在临床上的应用。 相似文献
8.
9.
《中国药物应用与监测》2005,(4)
2005年5月,解放军总医院顺应医院快速发展的要求,成立了医学保障部,由院党委直接领导。医学保障部下辖三所两中心,即医院管理研究所、基础医学所、医学信息情报所、药品保障中心、医学工程保障中心。药品保障中心是医院药学一级学科单位。中心设办公室,下辖8个科室:药品库、门诊药局、中药房、第一临床药局、第二临床药局、制剂室、药检室和临床药理药学研究室;和3个非编单位:全军药品不良反应监测中心、药学情报资料室、药品服务部。8个科室分别承担着药品的监督管理、供应保障、处方调配,制剂生产与药品质量控制,临床药学服务(AD R监测… 相似文献
10.
11.
目的分析评估我院近3年来药品不良反应(adverse drug reactions,ADR)报告质量状况。方法根据《药品不良反应报告和监测管理办法》及"药品不良反应/事件报告表"规范分级标准,对我院512份ADR报告质量进行分析,包括报表的规范性、完整性、加分项的正确率分析,同时对ADR的上报科室和上报类型进行了统计。结果我院ADR报告表数量逐年上升,报表的完整性和规范性亦呈逐年上升趋势,主要是一般的不良反应,但总体报告表的质量仍偏低,主要体现在完整性不高。且ADR报表大部分由所在科室的临床药师上报,主要集中于抗生素和中成药注射液。结论 ADR上报应提高规范性、完整性及正确率。发挥临床药师的专业优势是提高ADR报告表质量的一个重要因素。 相似文献
12.
13.
《Clinical Research and Regulatory Affairs》2013,30(1):65-72
AbstractThe Food and Drug Administration (FDA) has maintained a spontaneous voluntary system for the reporting of adverse drug events for over three decades. Based on the experience of the American Medical Association Registry for drug-related aplastic anemia, the current FDA spontaneous reporting system (FDA-SRS) was initiated in response to the public reaction to thalidomide induced phocomelia (1). A serious omission of the system has been a lack of focus on ADR observations by the health care provider. The Massachusetts Division of Food and Drugs was selected to participate in the pilot projects to promote reporting of adverse drug events. The Massachusetts Adverse Drug Reaction Project tried to increase the quantity and quality of adverse drug reaction reports filed by physicians. The basic focus of the project was to utilize various promotional mechanisms to convince providers that ADR reporting is an important public health safeguard. The project also attempted to facilitate access to reporting mechanisms. 相似文献
14.
Ying Zhao Tiansheng Wang Guangyao Li Shusen Sun 《International journal of clinical pharmacy》2018,40(4):823-831
Background Rational drug use and drug safety are becoming increasingly important concerns in China with the increasing public access to drugs and the health-care system, and this has led to the development of pharmacovigilance in China. Aim of the review To provide a brief introduction about pharmacovigilance in China in terms of system development, utilization and challenges. Method Relevant studies on pharmacovigilance related to the study aim was undertaken through literature search to synthesize the extracted data. Results The creation and evolvement of China’s pharmacovigilance system spans across 30 years since 1989. The system consists of four progressing administrative layers: county, municipal, provincial and national levels. China has passed over 20 laws and regulations related to pharmacovigilance covering the processes of drug development, manufacture, distribution and use with the aim to guard drug safety. An online spontaneous self-reporting Adverse Drug Reaction (ADR) Monitoring System was established in 2003. ADRs are mainly reported by medical institutions, pharmaceutical manufacturers, and drug distributors. Currently there is no mandatory ADR reporting requirement for pharmaceutical manufacturers, and a proposed regulation under public comment will likely change this. China has started to build active pharmacovigilance surveillance programs in addition to the passive ADR reporting system. The China Food and Drug Administration has established the intensive Safety Monitoring Program and the National Adverse Drug Reaction Monitoring Sentinel Alliance Program based on electronic health records to further the efforts of ADR reporting, monitoring and analysis. Conclusion The practice of ADR monitoring and pharmacovigilance in China have made great progress. More efforts are needed both in system building, and creation of laws and regulations to strengthen the safe use of medicines. 相似文献
15.
2003--2007年上海市药品不良反应报告表质量分析 总被引:2,自引:0,他引:2
目的:评价上海市2003—2007年药品不良反应(adverse drug reaction,ADR)报告表的质量。方法:根据《药品不良反应/事件报告表规范分级标准》对ADR报告表质量进行评价,影响ADR报告表质量的危险因素进行多个自变量的logistic逐步回归分析。结果:2003年12月-2007年4月上海市ADR报告总数为32752份。2006年已经达到每百万人口650份ADR报告,来源于医师的占61.94%,严重ADR比例为3.1%。影响ADR报告表质量的危险因素及优势比(OR)、95%可信区间(CI)为:新的严重ADR(OR=2.19,95%CI:1.38~3.47)、新的一般ADR(OR=2.13,95%CI:1.51~3.00)、已知严重ADR(OR--5.32,95%CI:4.15~6.81)、生产企业(OR--35.74,95%CI:28.27~45.19)、军队医院(OR=21.05,95%CI:14.62~30.32)、监测机构(OR=6.16,95%CI:2.38~15.92)、个人(OR=11.17,95%CI:2.33~53.43)、其他(OR=2.22,95%CI:1.04~4.76)。结论:上海市ADR报告百万人13每年上报率已达世界卫生组织(WHO)要求的标准,但整体质量仍需提高,建议加强ADR的宣传培训,充分发挥医师、药师和护十的作用,改善ADR榍告存纬录入功能. 相似文献
16.
17.
18.
An Adverse Drug Reaction Surveillance Program (ADRSP) was implemented by the pharmacy department of the University of Maryland Medical System to address the institution's underreporting of adverse drug reactions. The program aims were to increase the number and quality of significant adverse drug reaction (ADR) reports by facilitating and standardizing the reporting process, to more actively involve the pharmacy staff, and to create a comprehensive database, thus enabling the intervention of future untoward events. During the program's first 2 years, the number of ADR reports more than doubled, primarily due to increased pharmacists' participation. The ADRSP has facilitated the reporting process, enhanced the submission of ADR reports to the FDA, and helped prevent ADRs. 相似文献
19.